- Country: Brazil
- Summary: Price Registration, Aiming at Future and Possible Acquisitions of Oncological Medicines Part 2 Annual Plan 2024.
- BRT Ref No: 90120239
- Deadline: 24 Oct 2023
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 228/2023
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Object: Electronic Auction - Price registration, aiming at future and possible ACQUISITIONS OF ONCOLOGICAL MEDICINES PART 2 ANNUAL PLAN 2024.
UASG Code: 926775
Notice from: 06/10/2023 from 08:00 to 17:59 Hs
Proposal Delivery: from 10/06/2023 at 08:00
ALFAEPOETINA, CONCENTRATION19981d172c851bd4e8a1788d5726c2d340,000 IU/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity: 3000
INTERFERON, ALPHA 2B COMPOSITION, CONCENTRATION 5,000,000 IU, PHARMACEUTICAL FORMLYOPHIL POWDER FOR INJECTION
Quantity: 750
PHOSAPREPITANT DIMEGLUMINE, CONCENTRATION 15 0 MG, PHARMACEUTICAL FORM LYOPHILOP/ INJECTABLE POWDER
Quantity: 400
VAC19981d172c851bd4e8a1788d5726c2d3INA, BCG COMPOSITION, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION DILUENT
Quantity: 400
CYCLOPHOSPHAMIDE, CONCENTRATION 50 MG, PHARMACEUTICAL FORM PROLONGED RELEASE
Quantity: 4000
CISPLATIN, CONCENTRATION 1 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity ntity: 800
CISPLATIN, CONCENTRATION 119981d172c851bd4e8a1788d5726c2d3MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity: 3000
CHLORAMBUCILL, DOSAGE 2 MG
Quantity: 4500
DACARBAZINE, CONCENTRATION 100 MG, INJECTABLE USE
Quantity: 600
DACARBAZINE, CONCENTRATION 200 MG, INJECTABLE USE
Quantity : 2000
FLUORURACYL , DOSAGE 50 MG/ML, USE INJECTABLE SOLUTION
Quantity19981d172c851bd4e8a1788d5726c2d3ade: 1200
FLUORURACIL, DOSAGE 50 MG/ML, USE INJECTABLE SOLUTION
Quantity: 2000
HYDROXYUREA, DOSAGE 500 MG
Quantity: 100000
IDARRUBICIN HClORHYDRATE, DOSAGE 10 MG, INJECTABLE INDICATION
Quantity: 400
IFOSFAMIDE, DOSAGE 1 G, INJECTABLE APPLICATION
Quantity: 2500
IFHOSPHAMIDE, DOSAGE 0.5 G, A19981d172c851bd4e8a1788d5726c2d3INJECTABLE APPLICATION
Quantity: 450
LEUPRORELIN ACETATE, CONCENTRATION 7.5 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTABLE
Quantity: 500
LEUPRORELIN ACETATE, CONCENTRATION 22.5 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTABLE
Qua ntity: 3000
LEUPRORELIN ACETATE, CONCENTRATION 45 MG, PHARMACEUTICAL FORM19981d172c851bd4e8a1788d5726c2d3CEUTICA LYOPHIL POWDER FOR INJECTION, CHARACTER... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINPrice Registration, Aiming at Future and Possible Acquisitions of Oncological Medicines Part 2 Annual Plan 2024. - Brazil Tender
The STATE HEALTH FUND, a Government sector organization in Brazil, has announced a new tender for Price Registration, Aiming at Future and Possible Acquisitions of Oncological Medicines Part 2 Annual Plan 2024.. This tender is published on BrazilTenders under BRT Ref No: 90120239 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-10-24.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
